Revolution Medicines officer plans sale of 331 shares

An officer of Revolution Medicines has filed a Rule 144 notice to potentially sell 331 RSU-derived common shares through a broker after vesting in September 2026.

Available on EDGAR 09/15/2026 - 06:11 PM EDT Accepted by SEC EDGAR 09/15/2026 - 06:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Revolution Medicines, Inc. (RVMD) has a notice of proposed sale filed under Rule 144 for common stock held for the account of officer Alan B. Sandler. The filing covers up to 331 shares of common stock, to be sold through E*TRADE Financial Corporation after RSU vesting on September 15, 2026, as compensation for services rendered.

Key Figures

Shares covered by Rule 144 notice: 331 shares Proposed sale date reference: September 15, 2026 Aggregate market value reference: $67,447.87 +2 more

5 metrics

Shares covered by Rule 144 notice 331 shares Common stock for the account of officer Alan B. Sandler

Proposed sale date reference September 15, 2026 Date shown for the common stock and RSU vesting

Aggregate market value reference $67,447.87 Value shown alongside the 331 shares of common stock

Securities type Common stock Revolution Medicines, Inc. common stock under Rule 144 notice

RSU vesting basis Services rendered Reason listed for the RSU vesting that yields the shares

Key Terms

Rule 144, restricted stock units, RSU vesting, services rendered, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock units financial

"Common Stock | 09/15/2026 | RSU vesting | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU vesting financial

"Common Stock | 09/15/2026 | RSU vesting | Issuer"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

services rendered financial

"331 | 09/15/2026 | Services rendered"

attorney-in-fact regulatory

"Jack Anders, as Attorney-in-fact for Alan B Sandler"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for RVMD disclose?

It discloses a proposed sale under Rule 144 of up to 331 shares of Revolution Medicines, Inc. common stock for the account of officer Alan B. Sandler, with the shares tied to RSU vesting on September 15, 2026.

How many RVMD shares are covered by this Rule 144 notice?

The notice covers up to 331 shares of Revolution Medicines, Inc. common stock. This amount is associated with restricted stock units vesting on September 15, 2026 as compensation for services rendered.

Who is the person for whose account RVMD shares may be sold?

The shares may be sold for the account of Alan B. Sandler, identified as an officer. The notice is signed by Jack Anders acting as attorney-in-fact for Alan B. Sandler.

What is the planned timing of the RVMD share sale under this Form 144?

The filing indicates that the common stock is tied to RSU vesting on September 15, 2026. That date is used in the securities information and in the description of the RSU vesting and services rendered.

Which broker is listed for the proposed RVMD Rule 144 sale?

The proposed sale lists E*TRADE Financial Corporation, located in Alpharetta, Georgia, as the broker for the 331 shares of Revolution Medicines, Inc. common stock covered by the notice.

Does the Form 144 show RVMD shares sold in the past three months?

The section titled “Securities Sold During The Past 3 Months” is present in the notice, but no specific prior transactions are listed in the provided content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001835966
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Revolution Medicines, Inc.
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	650-481-6801
Name of Person for Whose Account the Securities are To Be Sold	Sandler Alan B
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005	331	67447.87	214336418	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/15/2026	RSU vesting	Issuer			331	09/15/2026	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jack Anders, as Attorney-in-fact for Alan B Sandler
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)